Gal Markel

6PUBLICATIONS
55CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors.

|Apr 19, 2023
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.

Ettai Markovits, Ortal Harush, Erez N Baruch

|Jun 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.

Naama Margolis, Hanna Moalem, Tomer Meirson

|Jan 15, 2021
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance.

Lir Beck, Michal Harel, Shun Yu

|Dec 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.

Erez N Baruch, Ilan Youngster, Guy Ben-Betzalel

|Nov 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.

Gilli Galore-Haskel, Eyal Greenberg, Inbal Yahav

Pageof 1

Frequent Collaborators

3 joint publications

Erez N Baruch

3 joint publications

Jacob Schachter

2 joint publications

Iris Barshack

2 joint publications

Michal J Besser